RayzeBio, Inc. Quarterly Operating Income (Loss) in USD from Q3 2022 to Q3 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
RayzeBio, Inc. quarterly Operating Income (Loss) history and growth rate from Q3 2022 to Q3 2023.
- RayzeBio, Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$21.7M, a 3.35% decline year-over-year.
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)